This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heath, D. G.
Right arrow Articles by Gilligan, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heath, D. G.
Right arrow Articles by Gilligan, P. H.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2002, p. 1188-1193, Vol. 40, No. 4
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.4.1188-1193.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Six-Year Molecular Analysis of Burkholderia cepacia Complex Isolates among Cystic Fibrosis Patients at a Referral Center for Lung Transplantation

David G. Heath,1,{dagger} Kathy Hohneker,2 Charlene Carriker,3 Kelly Smith,1 Jonathan Routh,1 John J. LiPuma,4 Robert M. Aris,2 David Weber,2,3,5 and Peter H. Gilligan1,6*

Clinical Microbiology-Immunology Laboratories,1 Department of Hospital Epidemiology, University of North Carolina Hospitals,3 Microbiology-Immunology,6 Medicine,2 Pediatrics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina,5 Department of Pediatrics and Communicable Diseases, The University of Michigan, Ann Arbor, Michigan4

Received 28 June 2001/ Returned for modification 26 October 2001/ Accepted 24 December 2001

Over a 6-year period, Burkholderia cepacia complex species were isolated from cystic fibrosis (CF) patients receiving care at The University of North Carolina Hospitals (clinic CF patients) and from those referred from other treatment centers. Fifty-six isolates collected from 30 referred patients and 26 clinic CF patients were characterized by pulsed-field gel electrophoresis (PFGE) and were assayed by PCR to detect the cable pilin gene, cblA. PFGE results indicated that six separate clusters (clusters A to F) were present among the 56 isolates and that three clusters (clusters A, B, and E) consisted only of isolates from referred patients infected with B. cepacia complex isolates prior to referral. However, one cluster (cluster C) consisted of isolates from four CF patients, and hospital records indicate that this cluster began with an isolate that came from a referred patient and that spread to three clinic CF patients. Cluster D consisted of two isolates from clinic CF patients, and hospitalization records are consistent with nosocomial, patient-to-patient spread. cblA was present in only 4 of the 56 isolates and included isolates in cluster E from the referred patients. Our results indicate a lack of spread of a previously characterized, transmissible clone from referred patients to our clinic CF population. Only two instances of nosocomial, patient-to-patient spread could be documented over the 6-year period. An additional spread of an isolate (cluster F) from a referred patient to a clinic patient could not be documented as nosocomial and may have been the result of spread in a nonhospitalized setting. The majority (36 of 56) of our B. cepacia complex-infected CF patients harbor isolates with unique genotypes, indicating that a diversity of sources account for infection. These data suggest that CF patients infected with B. cepacia complex and referred for lung transplantation evaluation were not a major source of B. cepacia complex strains that infected our resident CF clinic population.

* Corresponding author. Mailing address: Clinical Microbiology-Immunology Laboratories, University of North Carolina Hospitals CB 7600, Chapel Hill, NC 27514. Phone: (919) 966-6313. Fax: (919) 966-0486. E-mail: pgilliga{at}unch.unc.edu.

{dagger} Present address: Department of Pathology and Area Laboratory Services, Landstuhl Regional Medical Center, Landstuhl, Germany.

Journal of Clinical Microbiology, April 2002, p. 1188-1193, Vol. 40, No. 4
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.4.1188-1193.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Bosch, A., Minan, A., Vescina, C., Degrossi, J., Gatti, B., Montanaro, P., Messina, M., Franco, M., Vay, C., Schmitt, J., Naumann, D., Yantorno, O. (2008). Fourier Transform Infrared Spectroscopy for Rapid Identification of Nonfermenting Gram-Negative Bacteria Isolated from Sputum Samples from Cystic Fibrosis Patients. J. Clin. Microbiol. 46: 2535-2546 [Abstract] [Full Text]  
  • Baldwin, A., Mahenthiralingam, E., Drevinek, P., Pope, C., Waine, D. J., Henry, D. A., Speert, D. P., Carter, P., Vandamme, P., LiPuma, J. J., Dowson, C. G. (2008). Elucidating Global Epidemiology of Burkholderia multivorans in Cases of Cystic Fibrosis by Multilocus Sequence Typing. J. Clin. Microbiol. 46: 290-295 [Abstract] [Full Text]  
  • Campana, S., Taccetti, G., Ravenni, N., Favari, F., Cariani, L., Sciacca, A., Savoia, D., Collura, A., Fiscarelli, E., De Intinis, G., Busetti, M., Cipolloni, A., d'Aprile, A., Provenzano, E., Collebrusco, I., Frontini, P., Stassi, G., Trancassini, M., Tovagliari, D., Lavitola, A., Doherty, C. J., Coenye, T., Govan, J. R. W., Vandamme, P. (2005). Transmission of Burkholderia cepacia Complex: Evidence for New Epidemic Clones Infecting Cystic Fibrosis Patients in Italy. J. Clin. Microbiol. 43: 5136-5142 [Abstract] [Full Text]  
  • Brisse, S., Cordevant, C., Vandamme, P., Bidet, P., Loukil, C., Chabanon, G., Lange, M., Bingen, E. (2004). Species Distribution and Ribotype Diversity of Burkholderia cepacia Complex Isolates from French Patients with Cystic Fibrosis. J. Clin. Microbiol. 42: 4824-4827 [Abstract] [Full Text]  
  • De Soyza, A, Morris, K, McDowell, A, Doherty, C, Archer, L, Perry, J, Govan, J R W, Corris, P A, Gould, K (2004). Prevalence and clonality of Burkholderia cepacia complex genomovars in UK patients with cystic fibrosis referred for lung transplantation. Thorax 59: 526-528 [Abstract] [Full Text]  
  • Saiman, L., Siegel, J. (2004). Infection Control in Cystic Fibrosis. Clin. Microbiol. Rev. 17: 57-71 [Abstract] [Full Text]  
  • Turton, J. F., Kaufmann, M. E., Mustafa, N., Kawa, S., Clode, F. E., Pitt, T. L. (2003). Molecular Comparison of Isolates of Burkholderia multivorans from Patients with Cystic Fibrosis in the United Kingdom. J. Clin. Microbiol. 41: 5750-5754 [Abstract] [Full Text]  
  • Miller, M. B., Gilligan, P. H. (2003). Laboratory Aspects of Management of Chronic Pulmonary Infections in Patients with Cystic Fibrosis. J. Clin. Microbiol. 41: 4009-4015 [Full Text]  
  • Ramisse, V., Balandreau, J., Thibault, F., Vidal, D., Vergnaud, G., Normand, P. (2003). DNA-DNA hybridization study of Burkholderia species using genomic DNA macro-array analysis coupled to reverse genome probing. Int. J. Syst. Evol. Microbiol. 53: 739-746 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»